deltatrials
Recruiting OBSERVATIONAL NCT07131293

European Registry Study on Lymphatic Interventions (EURO-LYMPH)

European Registry Study on Lymphatic Interventions: Towards Standardized Care in CHD-Related Lymphatic Disorders

Sponsor: Bambin Gesù Hospital IRCCS, Rome, Italy

Updated 3 times since 2025 Last updated: Jan 19, 2026 Started: Feb 1, 2026 Primary completion: Mar 31, 2030 Completion: Mar 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07131293, this observational or N/A phase trial focuses on Chylothorax and Lymphatic Abnormalities and remains actively recruiting participants. Sponsored by Bambin Gesù Hospital IRCCS, Rome, Italy, it has been updated 3 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshotRecruiting~Oct 2025 – ~Feb 2026 · 4 months · monthly snapshotRecruiting~Feb 2026 – present · 4 months · monthly snapshotRecruiting

Change History

3 versions recorded
  1. Feb 2026 — Present [monthly]

    Recruiting

  2. Oct 2025 — Feb 2026 [monthly]

    Recruiting

  3. Sep 2025 — Oct 2025 [monthly]

    Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bambin Gesù Hospital IRCCS, Rome, Italy
  • Children's University Hospital, Ireland
  • Deutsches Herzzentrum Muenchen
  • Evelina London Children's Hospital
  • Guy's and St Thomas' NHS Foundation Trust
  • Hospital Universitari Vall d'hebron Barcelona, Spain
  • Hospital for Children and Adolescents, University of Helsinki
  • Lund University Hospital
  • Rigshospitalet, Denmark
  • UCL Bruxelles
  • UZ Gent, Belgium
  • UZ Leuven, Leuven, Belgium
  • University Hospital Schleswig-Holstein
  • University Hospital, Aachen
  • Universitätsklinikum Erlangen, Erlangen, Bayern, Germany
Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations